As a potent initiator of inflammation, MCP-1/CCL2 has been implicated in the development of numerous chronic disorders, including rheumatoid arthritis, cardiovascular diseases, and PCOS [28,29]. This evidence concerns the gene CCL2 and polycystic ovary syndrome.